Prima BioMed - 53 Year Dividend History | IMMP
Historical dividend payout and yield for Prima BioMed (IMMP) since 1971. The current TTM dividend payout for Prima BioMed (IMMP) as of December 20, 2024 is $0.00. The current dividend yield for Prima BioMed as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.295B |
$0.005B |
|
Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
